Safer Shot Stock Fundamentals
| SAFS Stock | USD 0.0001 0.00 0.00% |
Fundamental analysis of Safer Shot allows traders to better anticipate movements in Safer Shot's stock price by examining its financial health and performance throughout various phases of its business cycle.
Safer |
Safer Shot Company Return On Asset Analysis
Safer Shot's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Safer Shot Return On Asset | -0.5 |
Most of Safer Shot's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Safer Shot is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Safer Shot has a Return On Asset of -0.4996. This is 2.04% lower than that of the Industrials sector and 113.11% lower than that of the Aerospace & Defense industry. The return on asset for all United States stocks is notably higher than that of the company.
Safer Shot Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Safer Shot's current stock value. Our valuation model uses many indicators to compare Safer Shot value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Safer Shot competition to find correlations between indicators driving Safer Shot's intrinsic value. More Info.Safer Shot is currently regarded as top stock in return on asset category among its peers. It also is currently regarded number one company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Safer Shot's earnings, one of the primary drivers of an investment's value.Safer Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Safer Shot's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Safer Shot could also be used in its relative valuation, which is a method of valuing Safer Shot by comparing valuation metrics of similar companies.Safer Shot is currently under evaluation in return on asset category among its peers.
Safer Fundamentals
| Return On Asset | -0.5 | |||
| Current Valuation | 67.25 K | |||
| Shares Outstanding | 1.35 M | |||
| Net Income | (87.23 K) | |||
| Cash And Equivalents | 71 | |||
| Total Debt | 144.93 K | |||
| Book Value Per Share | (0.34) X | |||
| Cash Flow From Operations | (172) | |||
| Earnings Per Share | (0.69) X | |||
| Beta | -104.93 | |||
| Market Capitalization | 3.39 K | |||
| Total Asset | 110.49 K | |||
| Retained Earnings | (3.05 M) | |||
| Working Capital | (506 K) | |||
| Current Liabilities | 506 K | |||
| Z Score | -42.6 | |||
| Net Asset | 110.49 K |
About Safer Shot Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Safer Shot's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Safer Shot using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Safer Shot based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Safer Shot, Inc., a development stage company, engages in the development, manufacture, marketing, and sale of non-lethal hand held weapons. Safer Shot, Inc. was founded in 1997 and is headquartered in Annapolis, Maryland. SAFER SHOT is traded on PNK Exchange in the United States.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Safer Pink Sheet Analysis
When running Safer Shot's price analysis, check to measure Safer Shot's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safer Shot is operating at the current time. Most of Safer Shot's value examination focuses on studying past and present price action to predict the probability of Safer Shot's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safer Shot's price. Additionally, you may evaluate how the addition of Safer Shot to your portfolios can decrease your overall portfolio volatility.